Brett Giroir | |
---|---|
16th Assistant Secretary for Health | |
In office February 15, 2018 – January 19, 2021 | |
President | Donald Trump |
Secretary | Alex Azar |
Preceded by | Howard Koh |
Succeeded by | Rachel Levine |
Commissioner of Food and Drugs | |
Acting November 6, 2019 – December 17, 2019 | |
President | Donald Trump |
Preceded by | Norman Sharpless (acting) |
Succeeded by | Stephen Hahn |
Personal details | |
Born | Marrero, Louisiana, U.S. | November 4, 1960
Education | Harvard University (BA) University of Texas Southwestern (MD) |
Signature | |
Uniformed service | |
Allegiance | United States |
Service | United States Public Health Service Commissioned Corps |
Years of service | 2018–2021 |
Rank | Admiral |
Brett P. Giroir (pronounced jir-WAH) (born November 4, 1960)[1] is an American pediatrician. He was formerly the U.S. assistant secretary for health, a four-star admiral in the U.S. Public Health Service Commissioned Corps and an acting Food and Drug Administration commissioner.
From 2004 to 2008, Giroir served as the deputy director, and then a director, of DARPA's Defense Science Office, vice chancellor for the Texas A&M University System from 2008 to 2013, and as the chief executive officer of the Texas A&M Health Science Center from 2013 to 2015.[2]
Giroir starting in 2016 served as president and CEO of ViraCyte, LLC, a clinical-stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for severe infections. He also served as a senior fellow at the Texas Medical Center Health Policy Institute and strategic advisor for the Texas Medical Center Innovation Institute (TMCII). He was a member of the Texas Task Force for Infectious Disease Preparedness and Response, and an adjunct professor of pediatrics at the Baylor College of Medicine in Houston.[3]
Giroir served as the Acting Commissioner of Food and Drugs in November and December 2019, while Stephen Hahn's nomination was pending in the Senate.
theeagle1
was invoked but never defined (see the help page).